Alcured Tablets
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.
MFDS item code 201906282 · Approved 2019.09.04
This product's status changed to Approval withdrawn on 2024.03.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastrointestinal conditions (ulcers, gastritis, etc.) and Zollinger-Ellison syndrome; prevention of Mendelson syndrome
This medication is effectively used for gastrointestinal-related diseases such as gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome prior to anesthesia and aids in the treatment of ulcers that may occur post-surgery. It is utilized for the prevention and treatment of gastric and duodenal ulcers caused by the intake of non-steroidal anti-inflammatory drugs (NSAIDs). Thus, it contributes to managing various gastrointestinal diseases, alleviating symptoms, and promoting recovery, making it extremely useful for improving gastrointestinal health.
○ Adults Usually, administer 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or for combination therapy to prevent gastric or duodenal ulcers during long-term NSAID use. Conditions caused by NSAID use usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 1 tablet twice daily for 8 weeks or 2 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 1 tablet 3 times daily and increase the dose as needed. In severe cases, up to 6 g per day of ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 1 tablet twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet on the night before surgery.
This medication should not be used in patients with severely impaired kidney function or those undergoing dialysis, or in patients with a history of allergy to this medication or its components. It is also not safe to administer to patients with a rare blood disorder called acute porphyria. Patients with kidney issues or those who have undergone gastrointestinal surgery, pregnant women or those who may become pregnant, and premature infants or newborns must also not receive this medication. Patients on a potassium-restricted diet should not take this medication. Patients with liver function issues, those with a history of drug allergies, the elderly, patients with a history of kidney problems, and those taking NSAIDs should use this medication with caution. Especially since it may mask the symptoms of gastric cancer, it is crucial to confirm there are no malignant diseases in patients who have gastric ulcers or newly developed dyspeptic symptoms who are over middle age. Patients with gastric or duodenal ulcers infected with Helicobacter pylori require bacterial eradication therapy. Severe ICU patients, patients with hypophosphatemia, and those who have difficulty swallowing must also use this medication cautiously. When taking this medication, there is a rare likelihood of serious allergic reactions such as anaphylactic shock. Should symptoms appear, the medication must be discontinued immediately, and treatment sought. Hypersensitivity reactions such as skin rash, urticaria, angioedema, fever, bronchospasm, hypotension, and chest pain may also occur, requiring vigilant attention. Abnormal results may appear in blood tests, and abnormalities in liver function, arrhythmias, gastrointestinal symptoms (nausea, vomiting, constipation, diarrhea, etc.), and neurological symptoms (dizziness, drowsiness, confusion, seizures, etc.) have been reported. Additionally, various side effects such as myalgia or arthralgia, hair loss, and skin rashes may appear; it is essential to consult healthcare professionals if any abnormal symptoms occur. Long-term use is not recommended, and during treatment, regular monitoring of blood, liver, and kidney function is necessary, along with careful observation of symptoms. Elderly patients or those with chronic lung disease, diabetes, or weakened immune systems are at increased risk of pneumonia and must be especially cautious. If dizziness or drowsiness occurs while taking this medication, it is advisable to avoid driving or operating hazardous machinery. This medication may interact with other drugs; therefore, any concomitant medications should be disclosed to healthcare providers. Caution is essential when taken with anticoagulants, certain antibiotics, anticonvulsants, etc., and some medications are advised to be taken at a time interval from this medication. It is safest for pregnant or breastfeeding women to avoid this medication, and its safety in pediatric patients has not been established, so it is advisable to refrain from use. This medication may cause false positives in urine protein tests, so caution is required during testing. In the case of overdose, emergency measures such as vomiting or gastric lavage may be necessary, and in some cases, blood dialysis may be beneficial. This medication reduces gastric acid secretion, which may promote bacterial proliferation within the gastrointestinal tract, and prolonged use may have a characteristic of binding with ocular melanin, necessitating ophthalmological examinations.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is advisable to store it at room temperature between 1 to 30 degrees Celsius. Doing so will help maintain the medication's effectiveness for a long time.
Light green oblong film-coated tablet
10 tablets/bottle, 30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.